pirenzepine has been researched along with Hepatitis B, Chronic in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tamam, L | 1 |
Yerdelen, D | 1 |
Ozpoyraz, N | 1 |
1 other study available for pirenzepine and Hepatitis B, Chronic
Article | Year |
---|---|
Psychosis associated with interferon alfa therapy for chronic hepatitis B.
Topics: Adult; Antipsychotic Agents; Antiviral Agents; Benzodiazepines; Hepatitis B, Chronic; Humans; Interf | 2003 |